A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle
- 1 March 2000
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 25 (5) , 519-524
- https://doi.org/10.1038/sj.bmt.1702172
Abstract
Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.Keywords
This publication has 23 references indexed in Scilit:
- Multiple cycles of high-dose doxorubicin and cyclophosphamide with G-CSF mobilized peripheral blood progenitor cell support in patients with metastatic breast cancerAnnals of Oncology, 1997
- High-dose sequential chemotherapy with stem cell support for non-metastatic breast cancerBone Marrow Transplantation, 1997
- A Phase I and pharmacokinetic study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanomaCancer, 1997
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- Potential strategies for improving the results of high-dose chemotherapy in patients with metastatic breast cancerAnnals of Oncology, 1995
- Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study.Journal of Clinical Oncology, 1994
- Tamoxifen modulation of cisplatin cytotoxicity in human malignanciesInternational Journal of Cancer, 1993
- Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support.Journal of Clinical Oncology, 1990
- Diverse prognosis in metastatic breast cancer: Who should be offered alternative initial therapies?Breast Cancer Research and Treatment, 1989